{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:08:49Z","timestamp":1784117329068,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early identification of latent tuberculosis infection (LTBI) is essential for preventing active tuberculosis in heart transplant candidates and recipients, particularly in the context of immunosuppressive therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess and compare the prevalence of LTBI in patients awaiting heart transplantation and in heart transplant recipients using modern immunodiagnostic methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The prospective study was conducted between 2025 and 2026 and included patients listed for heart transplantation at the Almazov National Medical Research Centre. Patients were divided into two main groups according to whether heart transplantation was performed was conducted to evaluate immunodiagnostic: I group - patients prior to heart transplantation (\n                      <jats:italic>n<\/jats:italic>\n                      = 14) and the II group - in heart transplant recipients (\n                      <jats:italic>n<\/jats:italic>\n                      = 28). All patients included on the heart transplantation waiting list underwent a comprehensive assessment, which included detailed immunological testing. LTBI was assessed using (QuantiFERON\n                      <jats:sup>\u00ae<\/jats:sup>\n                      -TB Gold ELISA) and\/or a recombinant tuberculosis antigen skin test (Diaskintest). Statistical analysis was performed using Pearson\u2019s \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test, with significance set at\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LTBI prevalence was significantly higher in heart transplant recipients (53.6%) compared with controls (5.8%; \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      = 23.366,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). In pre-transplant patients, LTBI prevalence was 35.7%, also significantly exceeding that of controls (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      = 9.058,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003). The higher LTBI rates in both patient groups may reflect immune dysregulation associated with chronic heart failure and the effects of immunosuppressive therapy. Although LTBI prevalence was higher in transplant recipients than in pre-transplant patients, the difference was not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Heart transplant recipients demonstrate the highest prevalence of LTBI, followed by patients awaiting transplantation, both markedly exceeding that observed in healthy individuals. These findings indicate an elevated risk of active tuberculosis in this population and support the importance of routine LTBI screening and preventive therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1878586","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:10:19Z","timestamp":1784113819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of latent tuberculosis infection in patients prior to and following heart transplantation"],"prefix":"10.3389","volume":"13","author":[{"given":"Starshinova","family":"Anna","sequence":"first","affiliation":[{"name":"Almazov National Research Medical Center","place":["St. Petersburg, Russia"]},{"name":"Faculty of Mathematics and Computer Science, Saint Petersburg State University","place":["St. Petersburg, Russia"]},{"name":"Medical Department, Bashkir State Medical University of the Ministry of Health of the Russian Federation","place":["Ufa, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabirova","family":"Adilia","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics and Computer Science, Saint Petersburg State University","place":["St. Petersburg, Russia"]},{"name":"Medical Department, Bashkir State Medical University of the Ministry of Health of the Russian Federation","place":["Ufa, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedotov","family":"Petr","sequence":"additional","affiliation":[{"name":"Almazov National Research Medical Center","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaeva","family":"Bulgun","sequence":"additional","affiliation":[{"name":"Almazov National Research Medical Center","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharipov","family":"Raul","sequence":"additional","affiliation":[{"name":"Medical Department, Bashkir State Medical University of the Ministry of Health of the Russian Federation","place":["Ufa, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudryavtsev","family":"Igor","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Rubinstein","sequence":"additional","affiliation":[{"name":"Almazov National Research Medical Center","place":["St. Petersburg, Russia"]},{"name":"Institute of Experimental Medicine","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilyeva","family":"Elena","sequence":"additional","affiliation":[{"name":"Almazov National Research Medical Center","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stabrova","family":"Elena","sequence":"additional","affiliation":[{"name":"Almazov National Research Medical Center","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudlay","family":"Dmitry","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University","place":["Moscow, Russia"]},{"name":"FSBI SSC Institute of Immunology FMBA of Russia","place":["Moscow, Russia"]},{"name":"Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","volume-title":"Latent Tuberculosis Infection: Updated And Consolidated Guidelines For Programmatic Management.","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.micpath.2018.09.040","article-title":"Prevalence of latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis.","volume":"125","author":"Rahimifard","year":"2018","journal-title":"Microb Pathog"},{"key":"B3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5152\/thoracrespract.2024.23110","article-title":"Latent tuberculosis Infection management in solid organ transplantation recipients: a national snapshot.","volume":"25","author":"Alpayd\u0131n","year":"2024","journal-title":"Thorac Res Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"ofad324","DOI":"10.1093\/ofid\/ofad324","article-title":"Screening for latent tuberculosis infection in solid organ transplant recipients to predict active disease: a systematic review and meta-analysis of diagnostic studies.","volume":"10","author":"Yahav","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1378\/chest.111.2.365","article-title":"Tuberculosis in heart transplant recipients.","volume":"111","author":"K\u00f6rner","year":"1997","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d.","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.rcl.2023.04.010","article-title":"Immunosuppressive therapy in solid organ transplantation: primer for radiologists and potential complications.","volume":"61","author":"Tammisetti","year":"2023","journal-title":"Radiol Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/08923973.2021.1966033","article-title":"Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.","volume":"43","author":"Parlakpinar","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0005-2016","article-title":"Tuberculosis and transplantation.","volume":"4","author":"Aguado","year":"2016","journal-title":"Microbiol Specrt."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-023-00661-4","article-title":"Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: a national population-based study, 2008-2020.","volume":"23","author":"Hyun","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"B11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation.","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13259","DOI":"10.1111\/ctr.13259","article-title":"Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases.","volume":"32","author":"Abad","year":"2018","journal-title":"Clin Transpl"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish society of infectious diseases and clinical microbiology.","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3748\/wjg.v25.i26.3291","article-title":"Fluoroquinolones for the treatment of latent mycobacterium tuberculosis infection in liver transplantation.","volume":"25","author":"Silva","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: jacc state-of-the-art review.","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.cir.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure.","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"B17","first-page":"129","article-title":"Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates.","volume":"12","author":"Mardani","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13513","DOI":"10.1111\/ctr.13513","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American society of transplantation.","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transpl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e12971","DOI":"10.1111\/tid.12971","article-title":"Donor derived mycobacterium tuberculosis infection after solid-organ transplantation: a comprehensive review.","volume":"20","author":"Abad","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2333794X20981548","DOI":"10.1177\/2333794X20981548","article-title":"Tuberculosis in pediatric solid organ and hematopoietic stem cell recipients.","volume":"8","author":"Dubois","year":"2021","journal-title":"Glob Pediatr Heal."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e13268","DOI":"10.1111\/tid.13268","article-title":"Comparison of tuberculin skin test and interferon gamma release assay in pediatric candidates of heart transplantation and a 2-year follow-up.","volume":"22","author":"Sayyahfar","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.15829\/1560-4071-2024-6067","article-title":"Vaccination against a COVID-19 and predictors of COVID-19 development in patients after heart transplantation: a Russian multicenter observational study.","volume":"29","author":"Simonenko","year":"2024","journal-title":"Russ J Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/ejhf.942","article-title":"Immune mechanisms in heart failure.","volume":"19","author":"Zhang","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction.","volume":"72","author":"Tromp","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies.","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jmii.2025.08.027","article-title":"A novel application of the interferon-gamma release assay (IGRA) among end-stage heart failure patients awaiting heart transplantation.","volume":"59","author":"Tsai","year":"2026","journal-title":"J Microbiol Immunol Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jinf.2020.02.009","article-title":"Effect of HIV-infection on quantiFERON-plus accuracy in patients with active tuberculosis and latent infection.","volume":"80","author":"Petruccioli","year":"2020","journal-title":"J Infect"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20380","article-title":"Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.","volume":"20","author":"Auguste","year":"2016","journal-title":"Health Technol Assess"},{"key":"B30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/INF.0000000000004958","volume":"45","author":"Lazaro-Martin","year":"2026","journal-title":"Pediatr Infect Dis J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1111\/j.1600-6143.2009.02917.x","article-title":"Guidelines for vaccination of solid organ transplant candidates and recipients.","volume":"9","author":"Danzinger-Isakov","year":"2009","journal-title":"Am J Transplant."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1042461","DOI":"10.3389\/fmed.2023.1042461","article-title":"Evaluation of the specificity of an intradermal test with recombinant tuberculosis allergen in bacillus calmette-gu\u00e9rin-vaccinated healthy volunteers.","volume":"10","author":"Vasilyeva","year":"2023","journal-title":"Front Med."},{"key":"B33","first-page":"16","article-title":"NEW SCREENING AND DIAGNOSTIC OPTIONS OF VARIOUS TRAITS OF TB INFECTION AMONG CHILDREN AND ADOLESCENTS IN RUSSIA.","volume":"10","author":"Aksenova","year":"2011","journal-title":"Current Pediatrics."},{"key":"B34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21292\/2075-1230-2019-97-5-58-65","article-title":"Immunodiagnostics of tuberculosis: 10-year experience of using immunological tests in Russia.","volume":"97","author":"Starshinova","year":"2019","journal-title":"Tuberculosis and Lung Diseases."},{"key":"B35","doi-asserted-by":"publisher","first-page":"100782","DOI":"10.1016\/j.csite.2020.100782","article-title":"Experimental and numerical study of heat transfer and friction factor of plain tube with hybrid nanofluids.","volume":"22","author":"Ramadhan","year":"2020","journal-title":"Case Studies Therm Eng."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/S1526-0542(13)70092-7","article-title":"Results of QuantiFERON-TB gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection.","volume":"14","author":"Slogotskaya","year":"2013","journal-title":"Paediatr Resp Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0208705","DOI":"10.1371\/journal.pone.0208705","article-title":"Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow.","volume":"13","author":"Slogotskaya","year":"2018","journal-title":"PLoS One."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1878586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:10:20Z","timestamp":1784113820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1878586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1878586"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1878586","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1878586"}}